We did not include men with PSA<3ng/mL: since the decision to biopsy was based on PSA level, some of the controls with PSA<3ng/mL will have unidentified prostate cancer [6] (misclassification bias [51]). This evidence concerns the gene KLK3 and prostate cancer.